In the course of DKD progression, key inflammatory mediators—such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α)—are significantly upregulated [40,41]. The gene discussed is IL1B; the disease is diabetic kidney disease.